Trickle Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (1041)	2/4/2002 10:24:42 AM
From: nigel bates	Read Replies (1) of 1784

From Genomeweb - The company projects biodefense and chemical defense products to become a more significant part of revenues: These products recently represented only 7 percent of Bruker Daltonics revenue, but the firm expects that percentage to increase to 15 to 20 percent... nig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next